Zhejiang will focus on the development of biopharmaceutical industry


Zhejiang Province will strive to actively develop biopharmaceuticals, expand and expand pharmaceutical preparations, and accelerate the modernization of Chinese medicine. By the end of 2012, an important pharmaceutical industry base with strong domestic and foreign market competitiveness will be initially established.

The “Opinions on Promoting the Sustainable and Healthy Development of the Pharmaceutical Industry” recently issued by the General Office of the Zhejiang Provincial Government pointed out that Zhejiang Province will focus on the development of recombinant drugs such as monoclonal antibodies and cytokines, genetic engineering vaccines for disease prevention, and PCR for disease diagnosis and epidemic prevention ( Polymerase chain reaction, for the amplification of specific DNA fragments), biochips and other in vitro bio-diagnostic tests for new products. It also concentrated on the development of a number of new vaccines, biological reagents, and genetic engineering drugs with independent intellectual property rights to speed up industrialization.

At the same time, we will strengthen and expand pharmaceutical preparations, actively participate in drug registrations such as the US FDA, gradually increase the proportion of pharmaceutical preparations registered abroad, and strive to achieve new breakthroughs in the international market for pharmaceutical preparations. Form a batch of influential agents leading products and backbone enterprises.

The Zhejiang Provincial Government plans to accelerate the modernization of traditional Chinese medicine, organize the implementation of a batch of research and development of Chinese medicine innovative drugs with reliable curative effect, safe and reliable quality, and in-depth development of traditional advantageous varieties. Explore and establish a quality inspection method and control system that conforms to the characteristics of Chinese medicine and international standards, and focus on the development of "Zeba Eight Flavors" (refers to the Eight Flavors of Atractylodes Rhizome, White Peony, Fritillaria, Chrysanthemum, Corydalis, Scrophularia, Ophiopogon japonicus, Wenyujin, etc.) Traditional Chinese medicinal materials and Dendrobium candidum, etc. are standardized and planted in large scale.

It is understood that by the end of 2012, Zhejiang Province plans to significantly improve the independent innovation capability of the pharmaceutical industry, achieve a shift from generic drugs to imitation, and independent innovation drugs, and strive to achieve R&D investment of more than 4% of sales revenue, and new product output value. With a rate of more than 45%, exports are gradually expanding into major markets such as Europe, America and Japan.

We have got 220kV Transmission Line poles Quality Certificate from Power Industry Steel Tower Qualified Inspection & Test Center from 2001 year. Our steel poles are made from quality sheet through bending, forming, automatic welding and hot galvanization. We can reach one-run machining length of 14m and can bend sheet of thickness up to 45mm. We adopt advanced welding procedures, automatically weld main joints and reach rank-II welding quality.

We have supplied 2400ton 132kV and 220kV transmission line steel pole to WAPDA. Pakistan on 2008 and have supplied 1200ton 138kV transmission line steel pole to Davao light, Philippines on 2009.

Transmission Line Steel Tubular Pole

Transmission Line Steel Tubular Pole, Tubular Steel Pole, Steel Tubular Pole, Utility Pole

Jiangsu Xinjinlei Steel Industry Co., Ltd. , https://www.steel-pole.com